Celadon Pharmaceuticals Plc (LON:CEL – Get Free Report) hit a new 52-week low during trading on Monday . The stock traded as low as GBX 12 ($0.15) and last traded at GBX 12.68 ($0.16), with a volume of 8805 shares traded. The stock had previously closed at GBX 12.66 ($0.16).
Celadon Pharmaceuticals Stock Performance
The company’s 50-day moving average price is GBX 26.49 and its 200 day moving average price is GBX 49.49. The stock has a market capitalization of £8.73 million, a PE ratio of -156.25 and a beta of -0.26. The company has a debt-to-equity ratio of 194.82, a quick ratio of 6.97 and a current ratio of 1.92.
About Celadon Pharmaceuticals
Celadon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom.
Further Reading
- Five stocks we like better than Celadon Pharmaceuticals
- What is the Nikkei 225 index?
- How to Master Trading Discipline: Overcome Emotional Challenges
- What is a Dividend King?
- Trump Tax Reforms: 7 Stocks That Could Benefit in 2025
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 Stocks Near 52-Week Lows: Why They Could Be Smart Buys Today
Receive News & Ratings for Celadon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celadon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
